Vascular Access in Cancer Patients - PICC vs PORT in a Randomized Controlled Trial.

N/ACompletedNCT01971021

Linkoeping University400 enrolled

Overview

As of today there is very limited scientific knowledge in whicj of the two vascular access devices (PICC-line or venous ports) that offers the lowest complicationrates in cancerpatients. The study group wants to clearify this unsolved matter by comparing the two systems. Our primary endpoint is the presens of catheter related venous thrombosis. We are also looking at all catheter related complications and patient satisfaction.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

DOUBLE

Enrollment

400

Conditions

Focus of Study

Interventions

PICC or subcutaneous venous portDEVICE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 120 Years

Medical Language ↔ Plain English

Inclusion Criteria: * cancer treatment with need for central venous access * Age \>18 yrs * Suspected survival \> 4 weeks * Need of central venous access \>4 weeks Exclusion Criteria: * Ongoing uncontrolled systemic infection * Prescence of significant thrombosis/stenosis in arm or central veins * Unability to communicate * Probable upcoming need for dialysis fistula

Locations (1)

Dept of Oncology

Jönköping, Sweden

Outcomes

Primary Outcomes

The occurence of catheter related venous thrombosis

regular follow-ups at month 1, 3, 6 and 12.

Time frame: Upon clinical suspiscion during the one the patient i enrolled in the study

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.